As pointed out in the question, there are immune differences between those of African ancestry, and those from out of Africa.
We know from genetic studies that there is a major difference between African and out of African genetics
Ancient DNA has enabled us to answer long-standing questions about the relationship between archaic and modern humans. Admixture among archaic groups and between them and modern humans seems to have occurred whenever they came into geographic proximity. In that way, they were no different from groups of modern humans. Although most present-day human ancestry can be traced to African populations that dispersed into Eurasia ∼100,000 y ago, aDNA has allowed us to also determine which parts of our genomes are from archaic hominins that occupied Eurasia before modern humans (68): all non-African genomes carry small amounts of Neanderthal ancestry, and some carry an additional component of Denisovan ancestry.
So, the question is whether Neanderthal/Denisovan genes help protect against viral diseases such as SARS-CoV-2.
There are some hints that this might be the case in European populations:
Humans differ in the outcome that follows exposure to life-threatening pathogens, yet the extent of population differences in immune responses and their genetic and evolutionary determinants remain undefined. Here, we characterized, using RNA sequencing, the transcriptional response of primary monocytes from Africans and Europeans to bacterial and viral stimuli—ligands activating Toll-like receptor pathways (TLR1/2, TLR4, and TLR7/8) and influenza virus—and mapped expression quantitative trait loci (eQTLs). We identify numerous cis-eQTLs that contribute to the marked differences in immune responses detected within and between populations and a strong trans-eQTL hotspot at TLR1 that decreases expression of pro-inflammatory genes in Europeans only. We find that immune-responsive regulatory variants are enriched in population-specific signals of natural selection and show that admixture with Neandertals introduced regulatory variants into European genomes, affecting preferentially responses to viral challenges. Together, our study uncovers evolutionarily important determinants of differences in host immune responsiveness between human populations.
Genetic variation transmitted through admixture with Neandertals can also represent a source of functional, potentially advantageous variants (Vattathil and Akey, 2015). Relative to genome-wide expectations, we show that genetic segments introgressed from Neandertals have preferentially introduced regulatory variants into European genomes, affecting steady-state expression and responses to TLR7/8 stimulation and IAV. Furthermore, we report several loci presenting strong evidence of archaic ancestry that exert a regulatory effect in cis. Among these, we find the IAV-induced reQTL of PNMA1, which encodes a protein that physically interacts with the IAV protein PB2 and stimulates interferon production (Shapira et al., 2009). That the PNMA1 haplotype presents a frequency in Europeans that is not compatible with neutral evolution, together with its strong levels of population differentiation between modern Europeans and East Asians, supports its contribution to European adaptation and provides a case of adaptive introgression. The functional roles of the introgressed regulatory variants require further investigation, but our results clearly establish that archaic admixture, whether adaptive or not, has increased the diversity of the immune repertoire of contemporary Europeans.
So, it appears that the introduction of Neaderthal genes that influence immune responses has lead to an increased range of possible responses to viral infection than was possible from pure African genomes.
Genetic Adaptation and Neandertal Admixture Shaped the Immune System of Human Populations